MétaCan
Menu
Back to cohort
Record W3165649735 · doi:10.1111/all.14957

Technical standards in allergen exposure chambers worldwide – an EAACI Task Force Report

2021· article· en· W3165649735 on OpenAlexaff
Oliver Pfaar, Karl‐Christian Bergmann, С. Бонини, Enrico Compalati, Nathalie Domis, F. de Blay, Pieter‐Jan de Kam, Philippe Devillier, Stephen R. Durham, Anne K. Ellis, Alina Gherasim, Laura Haya, Jens M. Hohlfeld, Friedrich Horak, Tomohisa Iinuma, Robert L. Jacobs, Henrik H. Jacobi, Marek Jutel, Susanne Kaul, Suzanne Kelly, Ludger Klimek, Mark Larché, Patrick Lemell, Vera Mahler, Hendrik Nolte, Yoshitaka Okamoto, Piyush M. Patel, Ronald L. Rabin, Cynthia Rather, Angelika Sager, Anne Marie Salapatek, Torben Sigsgaard, Alkis Togias, Christoph Willers, William H. Yang, René Zieglmayer, Torsten Zuberbier, Petra Zieglmayer

Bibliographic record

VenueAllergy · 2021
Typearticle
Languageen
FieldMedicine
TopicAllergic Rhinitis and Sensitization
Canadian institutionsQueen's UniversityMcMaster UniversityInflamax Research (Canada)Kingston Health Sciences CentreRobarts Clinical TrialsProvidence Health CareKingston General Hospital
FundersEuropean Academy of Allergy and Clinical Immunology
KeywordsMedicineAllergyAllergen immunotherapyClinical trialAsthmaAllergenTask forceImmunologyClinical immunologyIntensive care medicinePathology

Abstract

fetched live from OpenAlex

Allergen exposure chambers (AECs) can be used for controlled exposure to allergenic and non-allergenic airborne particles in an enclosed environment, in order to (i) characterize the pathological features of respiratory diseases and (ii) contribute to and accelerate the clinical development of pharmacological treatments and allergen immunotherapy for allergic disease of the respiratory tract (such as allergic rhinitis, allergic rhinoconjunctivitis, and allergic asthma). In the guidelines of the European Medicines Agency for the clinical development of products for allergen immunotherapy (AIT), the role of AECs in determining primary endpoints in dose-finding Phase II trials is emphasized. Although methodologically insulated from the variability of natural pollen exposure, chamber models remain confined to supporting secondary, rather than primary, endpoints in Phase III registration trials. The need for further validation in comparison with field exposure is clearly mandated. On this basis, the European Academy of Allergy and Clinical Immunology (EAACI) initiated a Task Force in 2015 charged to gain a better understanding of how AECs can generate knowledge about respiratory allergies and can contribute to the clinical development of treatments. Researchers working with AECs worldwide were asked to provide technical information in eight sections: (i) dimensions and structure of the AEC, (ii) AEC staff, (iii) airflow, air processing, and operating conditions, (iv) particle dispersal, (v) pollen/particle counting, (vi) safety and non-contamination measures, (vii) procedures for symptom assessments, (viii) tested allergens/substances and validation procedures. On this basis, a minimal set of technical requirements for AECs applied to the field of allergology is proposed.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.245
metaresearch head score (Gemma)0.134
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Other · Consensus signal: Other
Teacher disagreement score0.245
Threshold uncertainty score0.931

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.2450.134
Meta-epidemiology (narrow)0.0020.002
Meta-epidemiology (broad)0.0020.003
Bibliometrics0.0080.005
Science and technology studies0.0040.004
Scholarly communication0.0080.005
Open science0.0120.006
Research integrity0.0150.009
Insufficient payload (model declined to judge)0.0070.011

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.013
GPT teacher head0.280
Teacher spread0.267 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

Study designNot applicable
Domainnot available
GenreOther

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations40
Published2021
Admission routes1
Has abstractyes

Explore more

Same venueAllergySame topicAllergic Rhinitis and SensitizationFrench-language works237,207